Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

JDFR supports development of vTv Therapeutics' TTP-399 for type 1 diabetes

Sep. 7, 2017

AbbVie submits NDA in U.S. for elagolix

Sep. 7, 2017

Janssen discovers prostanoid EP3 receptor antagonists with promising drug characteristics

Sep. 6, 2017

Biocon partners with JDRF for Insulin Tregopil trial in type 1 diabetes

Sep. 6, 2017

Ligand reports topline results from phase II trial of LGD-6972

Sep. 6, 2017

Concert Pharmaceuticals presents new PPARalpha, PPARdelta agonists

Sep. 5, 2017

FDA grants tentative approval to Sanofi's Admelog

Sep. 4, 2017

Midatech submits CTA to begin first-in-human study of MTD-201

Sep. 4, 2017

Mochida compound shows effective targeting of FFAR1 for diabetes

Sep. 1, 2017

European Commission approves pediatric formulation of Mimpara

Sep. 1, 2017

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...